Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines

The synthesis of new 4-amino substituted pyrazolo[3,4-d]pyrimidines along with their activity in cell-free enzymatic assays on Src and Abl tyrosine kinases is reported. Some compounds emerged as good dual inhibitors of the two enzymes, showed antiproliferative effects on two Bcr-Abl positive leukemi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of medicinal chemistry 2008-12, Vol.43 (12), p.2665-2676
Hauptverfasser: SCHENONE, Silvia, BRULLO, Chiara, BOTTA, Maurizio, BRUNO, Olga, BONDAVALLI, Francesco, MOSTI, Luisa, MAGA, Giovanni, CRESPAN, Emmanuele, CARRARO, Fabio, MANETTI, Fabrizio, TINTORI, Cristina
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2676
container_issue 12
container_start_page 2665
container_title European journal of medicinal chemistry
container_volume 43
creator SCHENONE, Silvia
BRULLO, Chiara
BOTTA, Maurizio
BRUNO, Olga
BONDAVALLI, Francesco
MOSTI, Luisa
MAGA, Giovanni
CRESPAN, Emmanuele
CARRARO, Fabio
MANETTI, Fabrizio
TINTORI, Cristina
description The synthesis of new 4-amino substituted pyrazolo[3,4-d]pyrimidines along with their activity in cell-free enzymatic assays on Src and Abl tyrosine kinases is reported. Some compounds emerged as good dual inhibitors of the two enzymes, showed antiproliferative effects on two Bcr-Abl positive leukemia cell lines K-562 and KU-812, and induced apoptosis, as demonstrated by the PARP assay. Docking studies have been also performed to analyze the binding mode of compounds under study and to identify the structural determinants of their interaction with both Src and Abl.
doi_str_mv 10.1016/j.ejmech.2008.01.034
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69862468</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69862468</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-6504b50788569c1049f2456aa99618b25331efa7e371104c30830d6ef68d7a893</originalsourceid><addsrcrecordid>eNpFkE1r3DAQhkVoaLZp_0EourSn2B19Wj6G0DaBQA9tT6UIWZITbW1r47ED219fhV3S0zDM874MDyEXDGoGTH_a1nE7Rv9QcwBTA6tByBOyYY02leBKviIb4FxUigt5Rt4gbgFAaYDX5IwZIbkEviHp-35aHiImvKRdykO-T94NND65YXVLyhN1U6Ah-z9puqe4rCFFpLmnsnJjmjLFtcMlLesSA2U31W4_u7-l5pe4lFX4XdY0ppCmiG_Jae8GjO-O85z8_PL5x_VNdfft6-311V3lJbCl0gpkp6AxRunWM5Btz6XSzrWtZqbjSggWe9dE0bBy9QKMgKBjr01onGnFOfl46N3N-XGNuNgxoY_D4KaYV7S6NZpLbQooD6CfM-Ice7srz7p5bxnYZ8V2aw-K7bNiC8wWxSX2_ti_dmMM_0NHpwX4cAQcFpf97Caf8IXj0BpVfhf_AMpMhes</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69862468</pqid></control><display><type>article</type><title>Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>SCHENONE, Silvia ; BRULLO, Chiara ; BOTTA, Maurizio ; BRUNO, Olga ; BONDAVALLI, Francesco ; MOSTI, Luisa ; MAGA, Giovanni ; CRESPAN, Emmanuele ; CARRARO, Fabio ; MANETTI, Fabrizio ; TINTORI, Cristina</creator><creatorcontrib>SCHENONE, Silvia ; BRULLO, Chiara ; BOTTA, Maurizio ; BRUNO, Olga ; BONDAVALLI, Francesco ; MOSTI, Luisa ; MAGA, Giovanni ; CRESPAN, Emmanuele ; CARRARO, Fabio ; MANETTI, Fabrizio ; TINTORI, Cristina</creatorcontrib><description>The synthesis of new 4-amino substituted pyrazolo[3,4-d]pyrimidines along with their activity in cell-free enzymatic assays on Src and Abl tyrosine kinases is reported. Some compounds emerged as good dual inhibitors of the two enzymes, showed antiproliferative effects on two Bcr-Abl positive leukemia cell lines K-562 and KU-812, and induced apoptosis, as demonstrated by the PARP assay. Docking studies have been also performed to analyze the binding mode of compounds under study and to identify the structural determinants of their interaction with both Src and Abl.</description><identifier>ISSN: 0223-5234</identifier><identifier>EISSN: 1768-3254</identifier><identifier>DOI: 10.1016/j.ejmech.2008.01.034</identifier><identifier>PMID: 18342402</identifier><identifier>CODEN: EJMCA5</identifier><language>eng</language><publisher>Kidlington: Elsevier</publisher><subject>Antineoplastic agents ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biological and medical sciences ; Cell Proliferation - drug effects ; Computer Simulation ; Drug Screening Assays, Antitumor ; Fusion Proteins, bcr-abl - antagonists &amp; inhibitors ; General aspects ; Humans ; Medical sciences ; Models, Chemical ; Molecular Structure ; Pharmacology. Drug treatments ; Protein Kinase Inhibitors - chemical synthesis ; Protein Kinase Inhibitors - chemistry ; Protein Kinase Inhibitors - pharmacology ; Protein-Tyrosine Kinases - antagonists &amp; inhibitors ; Pyrazoles - chemistry ; Pyrimidines - chemical synthesis ; Pyrimidines - chemistry ; Pyrimidines - pharmacology ; Recombinant Proteins - antagonists &amp; inhibitors ; src-Family Kinases ; Stereoisomerism ; Structure-Activity Relationship ; Tumor Cells, Cultured</subject><ispartof>European journal of medicinal chemistry, 2008-12, Vol.43 (12), p.2665-2676</ispartof><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-6504b50788569c1049f2456aa99618b25331efa7e371104c30830d6ef68d7a893</citedby><cites>FETCH-LOGICAL-c401t-6504b50788569c1049f2456aa99618b25331efa7e371104c30830d6ef68d7a893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20985711$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18342402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHENONE, Silvia</creatorcontrib><creatorcontrib>BRULLO, Chiara</creatorcontrib><creatorcontrib>BOTTA, Maurizio</creatorcontrib><creatorcontrib>BRUNO, Olga</creatorcontrib><creatorcontrib>BONDAVALLI, Francesco</creatorcontrib><creatorcontrib>MOSTI, Luisa</creatorcontrib><creatorcontrib>MAGA, Giovanni</creatorcontrib><creatorcontrib>CRESPAN, Emmanuele</creatorcontrib><creatorcontrib>CARRARO, Fabio</creatorcontrib><creatorcontrib>MANETTI, Fabrizio</creatorcontrib><creatorcontrib>TINTORI, Cristina</creatorcontrib><title>Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines</title><title>European journal of medicinal chemistry</title><addtitle>Eur J Med Chem</addtitle><description>The synthesis of new 4-amino substituted pyrazolo[3,4-d]pyrimidines along with their activity in cell-free enzymatic assays on Src and Abl tyrosine kinases is reported. Some compounds emerged as good dual inhibitors of the two enzymes, showed antiproliferative effects on two Bcr-Abl positive leukemia cell lines K-562 and KU-812, and induced apoptosis, as demonstrated by the PARP assay. Docking studies have been also performed to analyze the binding mode of compounds under study and to identify the structural determinants of their interaction with both Src and Abl.</description><subject>Antineoplastic agents</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Cell Proliferation - drug effects</subject><subject>Computer Simulation</subject><subject>Drug Screening Assays, Antitumor</subject><subject>Fusion Proteins, bcr-abl - antagonists &amp; inhibitors</subject><subject>General aspects</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Models, Chemical</subject><subject>Molecular Structure</subject><subject>Pharmacology. Drug treatments</subject><subject>Protein Kinase Inhibitors - chemical synthesis</subject><subject>Protein Kinase Inhibitors - chemistry</subject><subject>Protein Kinase Inhibitors - pharmacology</subject><subject>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</subject><subject>Pyrazoles - chemistry</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - chemistry</subject><subject>Pyrimidines - pharmacology</subject><subject>Recombinant Proteins - antagonists &amp; inhibitors</subject><subject>src-Family Kinases</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Tumor Cells, Cultured</subject><issn>0223-5234</issn><issn>1768-3254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1r3DAQhkVoaLZp_0EourSn2B19Wj6G0DaBQA9tT6UIWZITbW1r47ED219fhV3S0zDM874MDyEXDGoGTH_a1nE7Rv9QcwBTA6tByBOyYY02leBKviIb4FxUigt5Rt4gbgFAaYDX5IwZIbkEviHp-35aHiImvKRdykO-T94NND65YXVLyhN1U6Ah-z9puqe4rCFFpLmnsnJjmjLFtcMlLesSA2U31W4_u7-l5pe4lFX4XdY0ppCmiG_Jae8GjO-O85z8_PL5x_VNdfft6-311V3lJbCl0gpkp6AxRunWM5Btz6XSzrWtZqbjSggWe9dE0bBy9QKMgKBjr01onGnFOfl46N3N-XGNuNgxoY_D4KaYV7S6NZpLbQooD6CfM-Ice7srz7p5bxnYZ8V2aw-K7bNiC8wWxSX2_ti_dmMM_0NHpwX4cAQcFpf97Caf8IXj0BpVfhf_AMpMhes</recordid><startdate>20081201</startdate><enddate>20081201</enddate><creator>SCHENONE, Silvia</creator><creator>BRULLO, Chiara</creator><creator>BOTTA, Maurizio</creator><creator>BRUNO, Olga</creator><creator>BONDAVALLI, Francesco</creator><creator>MOSTI, Luisa</creator><creator>MAGA, Giovanni</creator><creator>CRESPAN, Emmanuele</creator><creator>CARRARO, Fabio</creator><creator>MANETTI, Fabrizio</creator><creator>TINTORI, Cristina</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20081201</creationdate><title>Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines</title><author>SCHENONE, Silvia ; BRULLO, Chiara ; BOTTA, Maurizio ; BRUNO, Olga ; BONDAVALLI, Francesco ; MOSTI, Luisa ; MAGA, Giovanni ; CRESPAN, Emmanuele ; CARRARO, Fabio ; MANETTI, Fabrizio ; TINTORI, Cristina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-6504b50788569c1049f2456aa99618b25331efa7e371104c30830d6ef68d7a893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Antineoplastic agents</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Cell Proliferation - drug effects</topic><topic>Computer Simulation</topic><topic>Drug Screening Assays, Antitumor</topic><topic>Fusion Proteins, bcr-abl - antagonists &amp; inhibitors</topic><topic>General aspects</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Models, Chemical</topic><topic>Molecular Structure</topic><topic>Pharmacology. Drug treatments</topic><topic>Protein Kinase Inhibitors - chemical synthesis</topic><topic>Protein Kinase Inhibitors - chemistry</topic><topic>Protein Kinase Inhibitors - pharmacology</topic><topic>Protein-Tyrosine Kinases - antagonists &amp; inhibitors</topic><topic>Pyrazoles - chemistry</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - chemistry</topic><topic>Pyrimidines - pharmacology</topic><topic>Recombinant Proteins - antagonists &amp; inhibitors</topic><topic>src-Family Kinases</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Tumor Cells, Cultured</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHENONE, Silvia</creatorcontrib><creatorcontrib>BRULLO, Chiara</creatorcontrib><creatorcontrib>BOTTA, Maurizio</creatorcontrib><creatorcontrib>BRUNO, Olga</creatorcontrib><creatorcontrib>BONDAVALLI, Francesco</creatorcontrib><creatorcontrib>MOSTI, Luisa</creatorcontrib><creatorcontrib>MAGA, Giovanni</creatorcontrib><creatorcontrib>CRESPAN, Emmanuele</creatorcontrib><creatorcontrib>CARRARO, Fabio</creatorcontrib><creatorcontrib>MANETTI, Fabrizio</creatorcontrib><creatorcontrib>TINTORI, Cristina</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHENONE, Silvia</au><au>BRULLO, Chiara</au><au>BOTTA, Maurizio</au><au>BRUNO, Olga</au><au>BONDAVALLI, Francesco</au><au>MOSTI, Luisa</au><au>MAGA, Giovanni</au><au>CRESPAN, Emmanuele</au><au>CARRARO, Fabio</au><au>MANETTI, Fabrizio</au><au>TINTORI, Cristina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines</atitle><jtitle>European journal of medicinal chemistry</jtitle><addtitle>Eur J Med Chem</addtitle><date>2008-12-01</date><risdate>2008</risdate><volume>43</volume><issue>12</issue><spage>2665</spage><epage>2676</epage><pages>2665-2676</pages><issn>0223-5234</issn><eissn>1768-3254</eissn><coden>EJMCA5</coden><abstract>The synthesis of new 4-amino substituted pyrazolo[3,4-d]pyrimidines along with their activity in cell-free enzymatic assays on Src and Abl tyrosine kinases is reported. Some compounds emerged as good dual inhibitors of the two enzymes, showed antiproliferative effects on two Bcr-Abl positive leukemia cell lines K-562 and KU-812, and induced apoptosis, as demonstrated by the PARP assay. Docking studies have been also performed to analyze the binding mode of compounds under study and to identify the structural determinants of their interaction with both Src and Abl.</abstract><cop>Kidlington</cop><pub>Elsevier</pub><pmid>18342402</pmid><doi>10.1016/j.ejmech.2008.01.034</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0223-5234
ispartof European journal of medicinal chemistry, 2008-12, Vol.43 (12), p.2665-2676
issn 0223-5234
1768-3254
language eng
recordid cdi_proquest_miscellaneous_69862468
source MEDLINE; Elsevier ScienceDirect Journals
subjects Antineoplastic agents
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Biological and medical sciences
Cell Proliferation - drug effects
Computer Simulation
Drug Screening Assays, Antitumor
Fusion Proteins, bcr-abl - antagonists & inhibitors
General aspects
Humans
Medical sciences
Models, Chemical
Molecular Structure
Pharmacology. Drug treatments
Protein Kinase Inhibitors - chemical synthesis
Protein Kinase Inhibitors - chemistry
Protein Kinase Inhibitors - pharmacology
Protein-Tyrosine Kinases - antagonists & inhibitors
Pyrazoles - chemistry
Pyrimidines - chemical synthesis
Pyrimidines - chemistry
Pyrimidines - pharmacology
Recombinant Proteins - antagonists & inhibitors
src-Family Kinases
Stereoisomerism
Structure-Activity Relationship
Tumor Cells, Cultured
title Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T15%3A57%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20biological%20evaluation%20and%20docking%20studies%20of%204-amino%20substituted%201H-pyrazolo%5B3,4-d%5Dpyrimidines&rft.jtitle=European%20journal%20of%20medicinal%20chemistry&rft.au=SCHENONE,%20Silvia&rft.date=2008-12-01&rft.volume=43&rft.issue=12&rft.spage=2665&rft.epage=2676&rft.pages=2665-2676&rft.issn=0223-5234&rft.eissn=1768-3254&rft.coden=EJMCA5&rft_id=info:doi/10.1016/j.ejmech.2008.01.034&rft_dat=%3Cproquest_cross%3E69862468%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69862468&rft_id=info:pmid/18342402&rfr_iscdi=true